EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic profiling of the Chinese population with extreme longevity identifies Lysophospholipid species as potential biomarkers for the human lifespan

Shaochang Wu, He Li, Maoqiang Yu, Xiaogang Hu, Shan Chao, Fan Yang, Shengying Qin

Maturitas · 2025

DOI: 10.1016/j.maturitas.2025.108379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Maturitas, 2025. Verfasst von Shaochang Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Lishui Key Laboratory of Brain Health and Severe Brain Disorders, Lishui Second People's Hospital, Lishui, China. Hauptthemen laut MEDLINE: Aging, Longevity, Lysophospholipids, Metabolome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Metabolic regulation plays a crucial role in extending the healthspan and lifespan across multiple organisms, including humans. Although numerous studies have identified the characteristics of the metabolome and potential biomarkers in long-lived populations worldwide, the metabolome landscape of Chinese centenarians remains largely unknown. This study characterised the plasma metabolic profiles of Chinese centenarians and nonagenarians and identified potential biomarkers of longevity. METHODS: A global untargeted metabolomics approach was used to analyze plasma samples from 65 centenarians (average age 101.72 ± 1.46 years), 53 nonagenarians (average age 98.92 ± 0.27 years), 47 older individuals (average age 64.66 ± 3.31 years), and 35 middle-aged participants (average age 33.91 ± 3.53 years) recruited from the Lishui region, an area of China well known for the longevity of its population. RESULTS: The plasma metabolic profiles of centenarians and nonagenarians differed significantly from those of the two younger populations. Specifically, 211 and 114 differentially abundant metabolites (DAMs) were identified in the centenarian and nonagenarian groups, respectively. The majority of these DAMs were glycerophosphoethanolamines, glycerophosphocholines, fatty esters, fatty alcohols, fatty acyls, and fatty acids and conjugates. For example, the circulating levels of LysoPA (20:2), LysoPA (20:3), LysoPC (16:0), LysoPC (18:2), and LysoPE (20:4) were significantly lower in centenarians than in the older and middle-aged groups. A similar pattern was also observed in the nonagenarian population. Notably, the plasma levels of five DAMs - LysoPA (20:3), LysoPC (18:2), LysoPE (20:4), PG (18:0/18:1), and PG (18:1/18:2) - were significantly and continuously reduced with the ageing process. Pearson correlation analysis revealed that the reduced abundance of LysoPA (20:3), LysoPC (18:2), LysoPE (20:4), LysoPE (24:0), PG (18:0/18:1), and PG (18:1/18:2) was significantly and negatively associated with lifespan, from middle-age to centenarian. ROC analysis indicated that LysoPA (20:3), LysoPC (18:2), LysoPE (20:4), LysoPE (24:0), PG (18:0/18:1), and PG (18:1/18:2), as well as the combination of these six DAMs (AUC = 0.9074), had high predictive power for the human longevity phenotype. CONCLUSION: This study elucidated the plasma metabolic landscape of centenarians and nonagenarians in China and identified several potential biomarkers for predicting human lifespan. Our findings will aid in understanding the metabolic regulation of longevity and may promote the clinical practice of gerontology in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingLongevityLysophospholipidsMetabolomeAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedBiomarkersChinaMetabolomicsEast Asian People

Stichwörter der Autor:innen

CentenariansLysophosphatidic acidLysophosphatidylcholineLysophosphatidylethanolamineMetabolomicsNonagenariansPlasma metabolites

Substanzen

BiomarkersLysophospholipids

Autor:innen und Institutionen

  • Department of Geriatrics, Lishui Key Laboratory of Brain Health and Severe Brain Disorders, Lishui Second People's Hospital, Lishui, China.
  • Research Center for Lin He Academician New Medicine, Institutes for Shanghai Pudong Decoding Life, Shanghai, China.
  • Department of Geriatrics, Lishui Key Laboratory of Brain Health and Severe Brain Disorders, Lishui Second People's Hospital, Lishui, China; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsy…
  • Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China. Electronic address: chinsir@sjtu.edu.cn.

Förderung

  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Wu, S., Li, H., Yu, M., Hu, X., Chao, S., Yang, F., & Qin, S. (2025). Metabolic profiling of the Chinese population with extreme longevity identifies Lysophospholipid species as potential biomarkers for the human lifespan. Maturitas. https://doi.org/10.1016/j.maturitas.2025.108379

Vancouver

Wu S, Li H, Yu M, Hu X, Chao S, Yang F, et al. Metabolic profiling of the Chinese population with extreme longevity identifies Lysophospholipid species as potential biomarkers for the human lifespan. Maturitas. 2025. doi:10.1016/j.maturitas.2025.108379

BibTeX
@article{Wu2025,
  author = {Wu, Shaochang and Li, He and Yu, Maoqiang and Hu, Xiaogang and Chao, Shan and Yang, Fan and Qin, Shengying},
  title = {Metabolic profiling of the Chinese population with extreme longevity identifies Lysophospholipid species as potential biomarkers for the human lifespan},
  journal = {Maturitas},
  year = {2025},
  doi = {10.1016/j.maturitas.2025.108379}
}
Kostenlos starten →